Dr. Robert G. Mennel, MD
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Perelman School of Med at the University of Pennsylvania (1970)
- Years since graduation
- 56
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 67
Licensed in Texas since 1979, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1970Medical school: Perelman School of Med at the University of Pennsylvania
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
TX license F6039 (first issued 1979; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Texas Oncology PA (1,014 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 67
- Services billed
- 10,358
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Injection, iron sucrose, 1 mg | 9,800 | 26 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 9,690 | 16 |
| Injection, gadobutrol, 0.1 ml | 3,200 | 36 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,951 | 32 |
| Injection, dexamethasone sodium phosphate, 1 mg | 500 | 19 |
| Injection, granisetron hydrochloride, 100 mcg | 230 | 12 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 59 | 42 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 58 | 18 |
| Administration of chemotherapy into vein, 1 hour or less | 51 | 27 |
| Blood test, comprehensive group of blood chemicals | 43 | 41 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.